Omini

Omini is a private healthcare technology company founded in 2019, focused on developing point-of-care lab-on-chip biosensing devices for immediate blood testing. Their technology allows for clinical-grade blood analyses to be conducted rapidly, enabling results within minutes at the patient's bedside or in near-patient settings. This innovation combines the accuracy of traditional lab tests with the convenience of portable tools, enhancing medical decision-making. The company's core products include handheld biosensors and multi-sensing blood testing strips, which work with a portable connected reader and a dedicated application for data transmission. This system facilitates real-time blood molecule identification and analysis, supporting chronic disease management and empowering both patients and healthcare providers with reliable diagnostic information. Omini's leadership team includes CEO Joanne Kanaan and CTO Anna Shirinskaya, who bring expertise in biochemistry, biophysics, and bioelectronics to the company.

• Employees 58
• Founded 2019